Real-World Evidence Evaluating Continuation Of Cdk4/6 Inhibitors Beyond First Progression In Hormone Receptor-Positive (Hr Plus ) Metastatic Breast Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2019)